Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
10 10 Search
2025
Prognostic prediction for inflammatory breast cancer patients using random survival forest modeling
Translational Oncology
2024
Predictive Modelling of Overall Survival in Adult Patients with Primary Diffuse Large B-cell Lymphoma of the Breast Using the Surveillance, Epidemiology, and End Results (SEER) Database
Recent Patents on Anti-Cancer Drug Discovery
2024
ER+/PR− phenotype exhibits more aggressive biological features and worse outcome compared with ER+/PR+ phenotype in HER2-negative inflammatory breast cancer
Scientific Reports
2023
Risk-dependent conditional survival analysis and annual hazard rate of inflammatory breast cancer
European Journal of Surgical Oncology
2022
Inflammatory breast cancer, trimodal treatment, and mortality: Does where you live matter?
Surgery
2021
Update on systemic treatment for newly diagnosed inflammatory breast cancer
Journal of Advanced Research
2021
Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age
Frontiers in Oncology
2020
Nomogram for Predicting the Overall Survival of Adult Patients With Primary Gastrointestinal Diffuse Large B Cell Lymphoma: A SEER- Based Study
Frontiers in Oncology
Additional cited-by details will be shown when available from Crossref